FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1997512876> ?p ?o ?g. }

• W1997512876 endingPage "528" @default.
• W1997512876 startingPage "528" @default.
• W1997512876 abstract "Editorials20 April 2010Statins for Primary Prevention in Older Adults: Who Is High Risk, Who Is Old, and What Denotes Primary Prevention?Susan J. Zieman, MD, PhD and Pamela Ouyang, MBBSSusan J. Zieman, MD, PhDFrom Johns Hopkins University School of Medicine, Baltimore, Maryland, 21224, and Johns Hopkins Bayview Medical Center, Baltimore, Maryland, 21224.Search for more papers by this author and Pamela Ouyang, MBBSFrom Johns Hopkins University School of Medicine, Baltimore, Maryland, 21224, and Johns Hopkins Bayview Medical Center, Baltimore, Maryland, 21224.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-152-8-201004200-00011 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Whether to treat older adults with statin medications for primary prevention of cardiovascular events remains a clinical conundrum. A number of observations with regard to increasing age stoke this dilemma: The association between elevated cholesterol levels and cardiovascular risk diminishes (1), risk-prediction tools (such as the Framingham risk score) become less accurate (2, 3), supporting clinical trial data become limited, and the decreasing life expectancy versus time to medication benefit constantly shifts. Additional downsides of statins for older adults include medication cost, polypharmacy, and possible side effects. Conversely, age alone makes older adults inherently high risk and statins reduce cardiovascular ...References1. Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, et al; Prospective Studies Collaboration. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 2007;370:1829-39. [PMID: 18061058] CrossrefMedlineGoogle Scholar2. Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation. 1991;83:356-62. [PMID: 1984895] CrossrefMedlineGoogle Scholar3. de Ruijter W, Westendorp RG, Assendelft WJ, den Elzen WP, de Craen AJ, le Cessie S, et al. Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ. 2009;338:a3083. [PMID: 19131384] CrossrefMedlineGoogle Scholar4. Glynn RJ, Koenig W, Nordestgaard BG, Shepard J, Ridker PM. Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial. Ann Intern Med. 2010;152:488-96. Google Scholar5. Yusuf S, Lonn E, Bosch J. Lipid lowering for primary prevention. Lancet. 2009;373:1152-5. [PMID: 19345816] CrossrefMedlineGoogle Scholar6. Ridker PM; JUPITER Study Group. Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial. Circulation. 2003;108:2292-7. [PMID: 14609996] CrossrefMedlineGoogle Scholar7. Mora S, Ridker PM. Justification for the Use of statins in primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)—can C-reactive protein be used to target statin therapy in primary prevention?. Am J Cardiol. 2006;97:33A-41A. [PMID: 16442935] CrossrefMedlineGoogle Scholar8. Ferrucci L, Corsi A, Lauretani F, Bandinelli S, Bartali B, Taub DD, et al. The origins of age-related proinflammatory state. Blood. 2005;105:2294-9. [PMID: 15572589] CrossrefMedlineGoogle Scholar9. Kritchevsky SB, Cesari M, Pahor M. Inflammatory markers and cardiovascular health in older adults. Cardiovasc Res. 2005;66:265-75. [PMID: 15820195] CrossrefMedlineGoogle Scholar10. Alexander KP, Newby LK, Cannon CP, Armstrong PW, Gibler WB, Rich MW, et al; American Heart Association Council on Clinical Cardiology. Acute coronary care in the elderly, part I: non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation. 2007;115:2549-69. [PMID: 17502590] MedlineGoogle Scholar11. Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M, et al; ASCOT investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet. 2003;361:1149-58. [PMID: 12686036] MedlineGoogle Scholar12. Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, et al; PROSPER study group. PROspective Study of Pravastatin in the Elderly at Risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002;360:1623-30. [PMID: 12457784] CrossrefMedlineGoogle Scholar13. Gutterman DD. Silent myocardial ischemia. Circ J. 2009;73:785-97. [PMID: 19282605] CrossrefMedlineGoogle Scholar14. Fleg JL, Gerstenblith G, Zonderman AB, Becker LC, Weisfeldt ML, Costa PT, et al. Prevalence and prognostic significance of exercise-induced silent myocardial ischemia detected by thallium scintigraphy and electrocardiography in asymptomatic volunteers. Circulation. 1990;81:428-36. [PMID: 2297853] CrossrefMedlineGoogle Scholar15. McClelland RL, Chung H, Detrano R, Post W, Kronmal RA. Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2006;113:30-7. [PMID: 16365194] CrossrefMedlineGoogle Scholar16. Elveback L, Lie JT. Continued high incidence of coronary artery disease at autopsy in Olmsted County, Minnesota, 1950 to 1979. Circulation. 1984;70:345-9. [PMID: 6744538] CrossrefMedlineGoogle Scholar17. Helfand M, Buckley DI, Freeman M, Fu R, Rogers K, Fleming C, et al. Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;151:496-507. [PMID: 19805772] LinkGoogle Scholar18. Genest J, McPherson R, Frohlich J, Anderson T, Campbell N, Carpentier A, et al. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult—2009 recommendations. Can J Cardiol. 2009;25:567-79. [PMID: 19812802] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: From Johns Hopkins University School of Medicine, Baltimore, Maryland, 21224, and Johns Hopkins Bayview Medical Center, Baltimore, Maryland, 21224.Disclosures: None disclosed. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M10-0521.Corresponding Author: Pamela Ouyang, MBBS, Division of Cardiology, A1-East, Johns Hopkins Bayview Medical Center, 4940 Eastern Avenue, Baltimore, MD 21224; e-mail, [email protected]edu.Current Author Addresses: Dr. Zieman: Carnegie 568, Johns Hopkins Hospital, 600 North Wolfe Street, Baltimore, MD 21287.Dr. Ouyang: Division of Cardiology, A1-East, Johns Hopkins Bayview Medical Center, 4940 Eastern Avenue, Baltimore, MD 21224. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoRosuvastatin for Primary Prevention in Older Persons With Elevated C-Reactive Protein and Low to Average Low-Density Lipoprotein Cholesterol Levels: Exploratory Analysis of a Randomized Trial Robert J. Glynn , Wolfgang Koenig , Børge G. Nordestgaard , James Shepherd , and Paul M Ridker Metrics Cited byWhat the Guidelines Do Not Say: Statin Non-benefit GroupsPrimary Prevention of Cardiovascular Disease with Statins in the ElderlyStatins in the primary prevention of cardiovascular diseaseControl de la dislipemia en grupos clínicos especiales: mujeres, ancianos, VIH, enfermedad renal crónica, pacientes con síndrome metabólicoStatin Therapy in Primary Prevention: New Insights Regarding Women and the ElderlyThe treatment of cholesterol: issues, effects and targets 20 April 2010Volume 152, Issue 8Page: 528-530KeywordsAtherosclerosisCardiovascular disease riskCholesterolElderlyHypercholesterolemiaHypertensionMyocardial infarctionStatins ePublished: 20 April 2010 Issue Published: 20 April 2010 Copyright & PermissionsCopyright © 2010 by American College of Physicians. All Rights Reserved.PDF downloadLoading ..." @default.
• W1997512876 created "2016-06-24" @default.
• W1997512876 creator A5041538228 @default.
• W1997512876 date "2010-04-20" @default.
• W1997512876 modified "2023-10-18" @default.
• W1997512876 title "Statins for Primary Prevention in Older Adults: Who Is High Risk, Who Is Old, and What Denotes Primary Prevention?" @default.
• W1997512876 cites W1607804102 @default.
• W1997512876 cites W1980205263 @default.
• W1997512876 cites W1995409872 @default.
• W1997512876 cites W2000165789 @default.
• W1997512876 cites W2028748749 @default.
• W1997512876 cites W2028948892 @default.
• W1997512876 cites W2031185570 @default.
• W1997512876 cites W2032788149 @default.
• W1997512876 cites W2052176508 @default.
• W1997512876 cites W2098432330 @default.
• W1997512876 cites W2101636105 @default.
• W1997512876 cites W2107794933 @default.
• W1997512876 cites W2122829469 @default.
• W1997512876 cites W2131137214 @default.
• W1997512876 cites W2161018651 @default.
• W1997512876 cites W2163106819 @default.
• W1997512876 doi "https://doi.org/10.7326/0003-4819-152-8-201004200-00011" @default.
• W1997512876 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20404384" @default.
• W1997512876 hasPublicationYear "2010" @default.
• W1997512876 type Work @default.
• W1997512876 sameAs 1997512876 @default.
• W1997512876 citedByCount "11" @default.
• W1997512876 countsByYear W19975128762013 @default.
• W1997512876 countsByYear W19975128762014 @default.
• W1997512876 crossrefType "journal-article" @default.
• W1997512876 hasAuthorship W1997512876A5041538228 @default.
• W1997512876 hasConcept C126322002 @default.
• W1997512876 hasConcept C1862650 @default.
• W1997512876 hasConcept C2779134260 @default.
• W1997512876 hasConcept C2984752397 @default.
• W1997512876 hasConcept C2993857929 @default.
• W1997512876 hasConcept C512399662 @default.
• W1997512876 hasConcept C71924100 @default.
• W1997512876 hasConcept C74909509 @default.
• W1997512876 hasConceptScore W1997512876C126322002 @default.
• W1997512876 hasConceptScore W1997512876C1862650 @default.
• W1997512876 hasConceptScore W1997512876C2779134260 @default.
• W1997512876 hasConceptScore W1997512876C2984752397 @default.
• W1997512876 hasConceptScore W1997512876C2993857929 @default.
• W1997512876 hasConceptScore W1997512876C512399662 @default.
• W1997512876 hasConceptScore W1997512876C71924100 @default.
• W1997512876 hasConceptScore W1997512876C74909509 @default.
• W1997512876 hasIssue "8" @default.
• W1997512876 hasLocation W19975128761 @default.
• W1997512876 hasLocation W19975128762 @default.
• W1997512876 hasOpenAccess W1997512876 @default.
• W1997512876 hasPrimaryLocation W19975128761 @default.
• W1997512876 hasRelatedWork W2003062385 @default.
• W1997512876 hasRelatedWork W2059504638 @default.
• W1997512876 hasRelatedWork W2474699632 @default.
• W1997512876 hasRelatedWork W2529518269 @default.
• W1997512876 hasRelatedWork W2637803346 @default.
• W1997512876 hasRelatedWork W2731609119 @default.
• W1997512876 hasRelatedWork W2795573598 @default.
• W1997512876 hasRelatedWork W3018010142 @default.
• W1997512876 hasRelatedWork W4235915738 @default.
• W1997512876 hasRelatedWork W4309365539 @default.
• W1997512876 hasVolume "152" @default.
• W1997512876 isParatext "false" @default.
• W1997512876 isRetracted "false" @default.
• W1997512876 magId "1997512876" @default.
• W1997512876 workType "article" @default.